Growth + Value Investor | SEBI Registered Research Analyst INH000021261 | Fundamental Analysis | SRCC | Contact : wa.link/r2j3y9

+91 85951 62794
Excited to share—we’re now SEBI Registered! After 2+ years of consistently sharing insights on X, we received several inquiries about launching our own research services. So, we decided to go ahead, get SEBI Registered, and launch our dedicated Research Desk, focused on uncovering high-growth opportunities in the Smallcap & Midcap space. We're now also live on Smallcase! There’s been a lot going on in the background over the last few months. Thanks for the continued support—we’ll keep striving to add value!❤️
133
17
633
250,266
Key insights from PB Fintech’s investor call on the proposed insurance distribution regulations & their likely impact: - Management gave an example where an agent currently earning around 15,000 for selling a fresh health insurance policy could receive only around 3,500-3,750 under the proposed structure. - Health insurance appears to be the most affected segment because commissions on both fresh business & renewals could decline sharply. - Management estimates that under the current proposal, GI economics could fall to only around one-third to 40% of current levels. Life insurance NPV economics are relatively similar to the existing structure, although not exactly the same. - PB Fintech’s core business REV mix is broadly 50% General Insurance & 50% Life Insurance. Management illustrated that if GI REV falls by around 60%, total core REV could initially compress by around 30% before considering volume growth or cost savings. - Policybazaar historically spends heavily acquiring younger customers upfront & earns economics over the customer lifecycle through renewals. A sharp reduction in renewal commissions can materially alter this model. Management said it now needs to determine how its existing economic arrangement with insurers evolves. - However, management believes lower commissions could translate into lower insurance prices for customers. PB operates with insurers through a combined operating ratio framework, so if distribution costs decline & savings are passed to customers, lower prices could drive additional volumes. - Management assumes price elasticity of around 1. This means every 1% reduction in insurance prices could potentially generate around 1% additional volumes. Based on this, management believes roughly 15-20% of the initial impact could potentially be recovered through higher growth. - Policybazaar is likely to shift from a "growth at any cost" approach toward more rational growth. Digital marketing, brand spending, hiring & customer acquisition will reduce going forward. - PB hired around 6,000 people in H1 because it was aggressively investing for growth. Management suggested that under the new economics, it might have hired closer to 2,000 instead. - The regulations could push PB Fintech to monetise services that are currently provided without separate REV. These include PB Garages, PB Care+, hospital networks, claims support, technology, administration & reinsurance related activities. - These services are operated through separate entities rather than the insurance distribution entity. Management therefore sees scope for potentially monetising them independently depending on how the final rules are structured. - One major strategic consequence could be PB Fintech moving further into insurance manufacturing. Management said the proposed rules increase the probability of Policybazaar eventually having its own manufacturing capability.
10
10
93
17,392
IT services stocks are sliding down TCS: -44% Infosys: -40% Wipro: -49% 5 year return divergence within the sector is massive
1
6
159
9,851
Anyone can make promises or paint an ambitious picture. Believe in actions, not words. Talk is cheap. Execution is what ultimately matters.
5
2
67
6,197
EV is the long term direction, but the transition will be gradual Most OEMs are still betting on a multi fuel Hybrids are gaining traction until charging infrastructure improves src : MOFSL
3
8
68
7,299
Valuations of exchanges in India vs AMCs BSE & NSE both trading at around 35x FY28E P/E Which one would you bet on? 👀 src: Emkay
17
8
103
12,086
AI related exposure is only around 16% of MSCI India Taiwan & Korea have 70-80% AI exposure, mainly through semiconductors & hardware China & Japan also have much higher exposure at around 30-50% src : Goldman Sachs
7
5
74
5,912
40% gone in a matter of 2 sessions Stocks climb through stairs and fall through elevators
12
1
146
24,771
PB Fintech 🔻30%, put premiums up 100x💀
7
1
196
12,799
Yesterday's closing of 1800 PE 3.7 Currently 500+
1
8
3,458
Regulatory risk is real & must never be ignored while investing We have seen this across multiple sectors: - IRDAI : commission caps, expense limits and distribution rules can directly impact insurers - RBI : lending rules, risk weights, provisioning norms, digital lending guidelines etc - SEBI : changes in F&O regulations, exchange frameworks, other regulations etc - Income Tax & GST : tax demands, retrospective interpretations, compliance disputes etc - US FDA : observations, warning letters or import alerts - TRAI / DoT - tariff rules, spectrum norms, telecom regulations - Environment authorities : approvals, pollution norms & plant shutdown risks for manufacturing companies - DGCA : regulatory changes for airlines & aviation companies - Government policy : duties, subsidies, import restrictions, export bans, PLI related changes etc There have also been episodes around hospital pricing regulations, gold import duty changes, windfall taxes, gaming GST changes & several others. We have seen several such examples over the years - Delta Corp, IIFL Finance, IEX and many others getting impacted because of regulatory or policy changes. This is why diversification matters!
3
15
84
9,188
Policybazaar today is a perfect example of how F&O stock price bands work F&O stocks do not have a fixed daily 10% or 20% circuit limit. Instead, they operate with dynamic price bands. Yesterday's close: 1,886.30 Initial 10% lower band: ~1,698 After first flex at 15%: ~1,603 After second flex at 20%: ~1,509 After third flex at 23%: ~1,452 After fourth flex at 26%: ~1,396 That is exactly why the chart looks like a staircase
20
9
266
57,490
For F&O stocks, the circuit system works differently from normal cash market stocks F&O stocks do not have a fixed 5%, 10% or 20% daily upper/lower circuit Instead, they operate with dynamic price bands The current NSE mechanism broadly works like this⏬
1
5
43
8,742
This is what a black swan like event looks like Policybazaar & Turtlemint are both down 20% today after IRDAI’s proposed changes to insurance distribution economics One consultation paper comes out & the market can reprice the entire business model within minutes
34
23
487
134,147
As an investor, there is nothing you can do in such situations That is exactly why diversification matters You can do all the research in the world, track management, understand the business and still wake up to an event you could never have predicted One regulatory announcement, one press release, one governance issue or one unexpected disruption - and suddenly the entire risk-reward changes. Diversification will not prevent such events But it can prevent one such event from damaging your entire portfolio Never let conviction turn into concentration risk We are not invested in either of these stocks, but this can happen to any stock in any portfolio someday
1
3
70
8,751
Insurance stocks in free fall after IRDAI consultation paper🔻 IRDAI has released a major consultation paper titled “Recalibrating Economics of Insurance Distribution”, proposing tighter controls on how much insurers can spend on distribution, commissions & customer acquisition. The biggest impact of IRDAI’s proposed changes could impact insurance distributors Policybazaar & Turtlemint primarily earn by distributing insurance products & receiving commissions from insurers. If commission caps come down, their take rates & unit economics get hit directly. This is potentially a significant reset of insurance distribution economics.
11
19
223
64,576
Interesting development from PI Industries! PI has developed India's first indigenously discovered insecticide after more than a decade of R&D. Discovering a new molecule typically takes 10-12 years, requires around $300 Mn of investment & has a success rate of just 1 in 100,000 molecules tested. - PI has spent over a decade building its R&D capabilities, with 700+ scientists, 250 PhDs & investments of several thousand Cr. - The new insecticide targets a domestic market opportunity of 3,000-4,000 Cr across crops such as chillies, rice, corn etc - The global market opportunity is estimated at $750-800 Mn. PI is targeting 10-15% market share over time, with plans to enter the US, Brazil and select Asian markets.
8
26
202
18,388
Just look at some of the valuations in the market right now: Azad Engineering - 127x Cupid - 260x MTAR - 162x Sansera Engineering - 83x Acutaas - 68x Syrma SGS - 90x Indo MIM - 96x Laurus Labs - 99x TD Power - 86x Aeroflex - 103x SETL - 85x Aditya Infotech - 95x Avalon Tech - 122x Sai Life - 92x Hitachi - 116x These are just a few examples It is a mix of almost every hot theme in the market - Precision Engineering, Aerospace, EMS, CDMO, AI ancillaries, etc 80-100x P/E has almost become normal for many stocks in these themes
46
77
945
115,390
Yes, these are TTM P/E multiples TTM P/E is not the right way to value high growth companies where earnings can scale rapidly But it still gives you a picture of how much optimism is already embedded in valuations Even on forward earnings, many of these companies continue to trade at expensive multiples There is absolutely no harm in participating in such themes Momentum can continue much longer than expected But at triple digit P/E the margin for disappointment becomes very small A slight earnings miss or simply a change in market sentiment can lead to a sharp valuation de-rating So if you are playing these high valuation momentum stories, understand what you are playing Enjoy the momentum, but have a proper exit strategy in place to protect the gains
1
32
6,165
NSE is set to list tomorrow At the upper IPO price of 1,785, NSE is valued at 4.42 lakh Cr At different listing prices: - 1,785 : 4.42 lakh Cr - 1,850 : 4.58 lakh Cr - 1,900 : 4.70 lakh Cr - 2,000 : 4.95 lakh Cr So, assuming NSE lists around 1,850, it could enter the league of India’s top 10 listed companies by market cap from day one Quite a massive debut for the country’s largest stock exchange
21
20
337
79,593